NYMC Faculty Publications
Long-Term Antiretroviral Therapy Mitigates Mortality and Morbidity Independent of HIV Tropism: 18 Years Follow-Up in a Women's Cohort
Author Type(s)
Faculty
DOI
10.1097/QAD.0000000000003337
Journal Title
AIDS
First Page
1979
Last Page
1986
Document Type
Article
Publication Date
11-15-2022
Department
Public Health
Abstract
OBJECTIVE: CXCR4 (X4)-tropic HIV-1 was found previously to herald CD4 + cell depletion and disease progression in individuals who were antiretroviral-naive or took combination antiretroviral therapy (cART) for less than 5 years. We updated this finding by investigating whether the deleterious effect of X4-tropic strains is mitigated by long-term cART. DESIGN: We examined morbidity and mortality in relation to HIV-1 tropism and cART in 529 participants followed up to 18 years in the Women's Interagency HIV Study; 91% were women of color. METHODS: Plasma-derived HIV-1 tropism was determined genotypically. RESULTS: We categorized participants according to the number of visits reported on cART after initiation. Group 1: three or less visits, 74% of these participants reporting no cART; group 2: at least four visits and less than 70% of visits on cART; group 3: at least 70% of visits on cART. AIDS mortality rates for participants in each group with X4 virus compared with those with R5 virus exclusively were, respectively: 62 vs. 40% ( P = 0.0088); 23% vs. 22% [nonsignificant (NS)]; 7% vs. 14% (NS). Kaplan-Meier curves showed accelerated progression to AIDS death or AIDS-defining illness in participants with three or less cART visits and X4 viruses ( P = 0.0028) but no difference in progression rates stratified by tropism in other groups. Logistic regression found that HIV-1 suppression for at least 10 semiannual visits (≥5 years total) mitigated X4 tropism's deleterious effect on mortality, controlling for maximal viral load, and CD4 + nadir. CONCLUSION: Long-term cART markedly mitigated the deleterious effect of X4 viruses on AIDS morbidity and mortality. Mitigation was correlated with duration of viral suppression, supporting HIV-1 suppression as a crucial goal.
Recommended Citation
Weiser, B., Shi, B., Kemal, K., Burger, H., Minkoff, H., Shi, Q., Gao, W., Robison, E., Holman, S., Schroeder, T., Gormley, A., Anastos, K., & Ramirez, C. (2022). Long-Term Antiretroviral Therapy Mitigates Mortality and Morbidity Independent of HIV Tropism: 18 Years Follow-Up in a Women's Cohort. AIDS, 36 (14), 1979-1986. https://doi.org/10.1097/QAD.0000000000003337
